What does Allarity Therapeutics, Inc. do?
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics…
What is Allarity Therapeutics, Inc.'s P/E and P/B ratio?
Allarity Therapeutics, Inc. has a P/E ratio of -1.1 and a P/B ratio of 3.81.
What is Allarity Therapeutics, Inc.'s debt-to-equity ratio?
Allarity Therapeutics, Inc. has a debt-to-equity ratio of 6.30.
How much does Allarity Therapeutics, Inc. owe compared with what it owns?
Allarity Therapeutics, Inc. owes $0.89 for every $1 it owns (balance sheet Jun 2026), which is high.
What is Allarity Therapeutics, Inc.'s Positivity rank?
Allarity Therapeutics, Inc. is ranked #5,954 of 6,774 companies globally and #3,347 of 4,000 in United States on PositoAI, with a Positivity Score of 13,504.
Does Allarity Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Allarity Therapeutics, Inc..
Where can I read the latest news about Allarity Therapeutics, Inc.?
Recent headlines about Allarity Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Allarity Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Allarity Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.